⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

October 7, 2016Therapeutic Drug Monitoring

Development and Validation of an HPLC-UV Assay for the Therapeutic Monitoring of the New Antiepileptic Drug Perampanel in Human Plasma

Valentina Franco Roberto Marchiselli Cinzia Fattore Elena Tartara Giovambattista De Sarro Emilio Russo Emilio Perucca

View at Publisher

Ask AI

Bookmark

Share

Abstract

The present assay is simple, specific, and cost effective with performance characteristics suitable for TDM use.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Franco et al. (2016) studied this question.

synapsesocial.com/papers/69d7e47261e2ce1627d184bb https://doi.org/10.1097/ftd.0000000000000350

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Targeting α-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate receptors in epilepsyHuman Clinical Trial · 2014 · 45 citations
2Concentration–effect relationships with perampanel in patients with pharmacoresistant partial‐onset seizuresRCT · 2013 · 153 citations
3Perampanel Serum Concentrations in Adults With EpilepsyRetrospective Study · 2016 · 66 citations
4Perampanel for adjunctive treatment of partial‐onset seizures: A pooled dose–response analysis of phase III studiesRCT · 2014 · 59 citations
5Analysis of pooled phase III trials of adjunctive perampanel for epilepsy: Impact of mechanism of action and pharmacokinetics on clinical outcomesRCT · 2015 · 47 citations

HPLC with fluorescence detection assay of perampanel, a novel AMPA receptor antagonist, in human plasma for clinical pharmacokinetic studies2015
An inter‐laboratory cross‐validation study for the determination of perampanel in human plasma by liquid chromatography assays2016
Assessment of Interpatient and Intrapatient Variability of Dasatinib and Imatinib Concentrations in Patients With Chronic Myeloid Leukemia via Volumetric Absorptive Microsampling at HomeTherapeutic Drug Monitoring · 2026
Serum Profiles of Pembrolizumab, Cardiac Troponin T, and Interleukin-6 in a Plasma Exchange–Treated Patient With Immune Checkpoint Inhibitor–Related MyocarditisTherapeutic Drug Monitoring · 2026
Quantification of Upadacitinib, Dasatinib, Ruxolitinib, Imatinib, and Cabozantinib in Plasma With Liquid Chromatography-Tandem Mass SpectrometryTherapeutic Drug Monitoring · 2026

More from Therapeutic Drug Monitoring

More from University of Pavia